| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
An Approach to Rationalize Partitioning Sample Size into Individual Regions in a Multiregional Trial
|
Kawai, Norisuke
|
|
|
42 |
2 |
p. 139-147
|
article
|
| 2 |
2008 EuroMeeting Student Poster Abstracts
|
|
|
|
42 |
2 |
p. 201-204
|
article
|
| 3 |
Exact Tests for Epidemiological Risks under Independent Negative Binomial Sampling for Rare Events in Clinical Trials
|
Kang, Seung-Ho
|
|
|
42 |
2 |
p. 115-121
|
article
|
| 4 |
Getting Better Clinical Trial Data: An Inverted Viewpoint
|
Hattemer-Apostel, Rita
|
|
|
42 |
2 |
p. 123-130
|
article
|
| 5 |
Mega Mergers: A Systematic Approach to the Integration of Two Medical Information Departments
|
Gazo, Andrew
|
|
|
42 |
2 |
p. 183-191
|
article
|
| 6 |
Metrics Implementation in an Industry-Based Medical Information Department and Comparison to Metrics Tracked within Other Industry-Based Medical Information Departments
|
Soares, Stacey C.
|
|
|
42 |
2 |
p. 175-182
|
article
|
| 7 |
Monitoring Clinical Trial Data Using an Unblinded Industry Statistician
|
Baggs, Geraldine E.
|
|
|
42 |
2 |
p. 193-199
|
article
|
| 8 |
Pharmaceutical and Analytical Quality Control Services: Ownership or Outsourcing—A South African Case Study
|
Leng, Henry M. J.
|
|
|
42 |
2 |
p. 161-173
|
article
|
| 9 |
Preparing the Common Technical Document for Registration of Pharmaceuticals for Human Use (CTD)—Insights and Recommendations
|
Roth, Robert I.
|
|
|
42 |
2 |
p. 149-159
|
article
|
| 10 |
Sample Size Requirements for Clinical Trials with Repeated Binary Outcomes
|
Ahn, Chul
|
|
|
42 |
2 |
p. 107-113
|
article
|
| 11 |
“Substantial Evidence” from a Replicated Secondary Analysis, Followed by a Single Prospective Confirmatory Study
|
Denne, Jonathan
|
|
|
42 |
2 |
p. 131-138
|
article
|
| 12 |
The Impact of Incorporating Clinical Relevance on the Feasibility of Clinical Trials
|
Houschke, Dieter
|
|
|
42 |
2 |
p. 99-106
|
article
|
Journal description